Lantus solostar 100 unit/ML 3ML
Ended Awarded
- Contract number
- SPE2DB25FPSKJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,837
Award facts
- Contract value 100% obligated
- $1,836.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,836.66 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin, a critical diabetes management medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 30, 2025. The delivery order was issued on September 29, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio with DLA focused on supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal medical procurement requirements and serve critical healthcare customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for insulin exemplifies the routine pharmaceutical resupply operations conducted under the larger DLA prime vendor agreement.
Quick answers
Who was awarded contract SPE2DB25FPSKJ?
SPE2DB25FPSKJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FPSKJ worth?
The government has obligated $1,837 on SPE2DB25FPSKJ.
Is contract SPE2DB25FPSKJ an order under another contract?
Yes. SPE2DB25FPSKJ is a delivery order under SPE2DB25D2203, an indefinite delivery contract.
Was contract SPE2DB25FPSKJ competed?
The extent of competition for SPE2DB25FPSKJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award